Singapore markets closed
Straits Times Index
3,301.78 +4.23 (+0.13%) S&P 500
5,482.02 +8.79 (+0.16%) Dow
38,878.79 +100.69 (+0.26%) Nasdaq
17,844.08 -12.94 (-0.07%) Bitcoin USD
64,748.59 -611.45 (-0.94%) CMC Crypto 200
1,348.86 -40.55 (-2.92%)
Alar Pharmaceuticals Inc. (6785.TWO)
Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
At close: 01:30PM CST
Currency in TWD
Valuation measures4
| Market cap (intra-day) | 16.53B |
| Enterprise value | 13.94B |
| Trailing P/E | 34.44 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 13.50k |
| Price/book (mrq) | 6.39 |
| Enterprise value/revenue | 12.90k |
| Enterprise value/EBITDA | 32.45 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.22 |
| 52-week change 3 | 44.74% |
| S&P500 52-week change 3 | 24.71% |
| 52-week high 3 | 465.00 |
| 52-week low 3 | 116.00 |
| 50-day moving average 3 | 281.99 |
| 200-day moving average 3 | 245.65 |
Share statistics
| Avg vol (3-month) 3 | 628.82k |
| Avg vol (10-day) 3 | 265.1k |
| Shares outstanding 5 | 66.8M |
| Implied shares outstanding 6 | 67.07M |
| Float 8 | 40.14M |
| % held by insiders 1 | 45.29% |
| % held by institutions 1 | 13.38% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 1.5 |
| Forward annual dividend yield 4 | 0.61% |
| Trailing annual dividend rate 3 | 1.50 |
| Trailing annual dividend yield 3 | 0.61% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 05 Jun 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 87.64% |
| Operating margin (ttm) | 80.96% |
Management effectiveness
| Return on assets (ttm) | 14.22% |
| Return on equity (ttm) | 26.67% |
Income statement
| Revenue (ttm) | 469.27M |
| Revenue per share (ttm) | 7.97 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | 382.15M |
| Net income avi to common (ttm) | 411.28M |
| Diluted EPS (ttm) | 7.18 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.59B |
| Total cash per share (mrq) | 38.81 |
| Total debt (mrq) | 1.08M |
| Total debt/equity (mrq) | 0.04% |
| Current ratio (mrq) | 35.07 |
| Book value per share (mrq) | 38.71 |
Cash flow statement
| Operating cash flow (ttm) | 282.43M |
| Levered free cash flow (ttm) | 144.41M |
© 2024 Yahoo. All rights reserved.